Berlin Cures Holding AG

BRIEF

published on 08/29/2024 at 08:05, 3 months 23 days ago

Berlin Cures Welcomes Renowned Immunologist Professor Danny Altmann to its Advisory Board

Advisory Board Long Covid Clinical Trials Immunology Biomedical Research
PRESS RELEASE

published on 08/29/2024 at 08:00, 3 months 23 days ago

Berlin Cures Welcomes Renowned Immunologist Professor Danny Altmann to its Advisory Board
Berlin Cures appoints immunologist Professor Danny Altmann to Advisory Board for drug research and development in autoimmune diseases, including Long COVID

Advisory Board Long Covid Berlin Cures Autoimmune Diseases Danny Altmann
BRIEF

published on 06/26/2024 at 08:05, 5 months 25 days ago

Berlin Cures Announces Changes to Board of Directors to Propel Development of BC 007

Board Of Directors Long Covid Drug Development Berlin Cures BC 007
PRESS RELEASE

published on 06/26/2024 at 08:00, 5 months 25 days ago

Berlin Cures announces changes to Board of Directors to further propel the development of BC 007
Berlin Cures appoints Craig T. Basson, Gerrard Terlouw, and Oliver von Stein to its Board of Directors to drive development of BC 007 for Long COVID and cardiovascular disease

Board Of Directors Long Covid Berlin Cures BC 007 Cardiovascular Disease
BRIEF

published on 04/23/2024 at 08:05, 7 months 28 days ago

Berlin Cures Completes Screening Phase of BC 007 Trial in Fight Against Long COVID

Clinical Research Berlin Cures Phase II Trial BC 007 Long COVID Treatment
PRESS RELEASE

published on 04/23/2024 at 08:00, 7 months 28 days ago

Screening completed: Berlin Cures achieves key milestone in BC 007 Phase II Trial for treatment of Long COVID
Berlin Cures achieves key milestone in BC 007 Phase II trial for Long COVID treatment by successfully completing patient screening, marking a significant step in developing an effective therapy

Berlin Cures Phase II Trial BC 007 Long COVID Treatment Patient Screening
BRIEF

published on 04/03/2024 at 08:05, 8 months 18 days ago

Berlin Cures Boosts Research and Development with New Advisory Board

Biotechnology Advisory Board Long Covid Clinical Trial Berlin Cures
PRESS RELEASE

published on 04/03/2024 at 08:00, 8 months 18 days ago

Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board
Berlin Cures appoints six renowned scientists to new advisory board to enhance research capabilities and support market launch of therapies, including for Long COVID

Advisory Board Long Covid Berlin Cures Scientists Research Capabilities
BRIEF

published on 03/04/2024 at 12:05, 9 months 17 days ago

Berlin Cures Reaches Key Milestone in Phase II Trial for Long COVID Treatment

Long Covid Berlin Cures Phase II Trial BC 007 Autoimmune Diseases
PRESS RELEASE

published on 03/04/2024 at 12:00, 9 months 17 days ago

Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Berlin Cures reaches over 50% patient recruitment in Phase II trial for Long COVID treatment with BC 007, aiming to neutralize harmful autoantibodies. CEO emphasizes global impact and urgent need for innovative solutions

Long Covid Berlin Cures Phase II Trial Autoantibodies Innovative Treatment

Published on 12/21/2024 at 01:30, 12 hours 39 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 39 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 14 hours 4 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 14 hours 9 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 39 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 13 hours 18 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 13 hours 24 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 18 hours 58 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 19 hours 13 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 20 hours 9 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 51 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 20 hours 9 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 20 hours 14 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News